This doesn't seem to be the same reference, but it is similar
http://www.clinchem.org/cgi/content/abstract/44/11/2301
http://www.ncbi.nlm.nih.gov/pubmed/1534 ... d_RVDocSum
Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area
http://atvb.ahajournals.org.proxy.cc.ui ... 28/10/1851
Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease
http://archinte.ama-assn.org.proxy.cc.u ... /168/6/598
Conclusions There are independent, continuous associations between Lp(a) levels and risk of future CHD in a broad range of individuals. Levels of Lp(a) are highly stable within individuals across many years and are only weakly correlated with known risk factors. Further assessment of their possible role in CHD prevention is warranted.
godsilove wrote:
We know through several large clinical trials that statins reduce all-cause mortality. A meta-analysis conducted by the Cholesterol Treatment Trialist's (CTT) group in 2005 demonstrates that statins reduce the risk of all-cause mortality and mortality from coronary heart disease, proportional to the reduction in LDL-cholesterol. A 1 mmol/L reduction in LDL, for instance, reduced both mortality as well as the incidence of major vascular events in the treatment arm.
I can point to a similar study that showed a more striking effect of low serum vitamin C levels and the increased mortality of an elderly population in the United Kingdom.
http://www.ncbi.nlm.nih.gov/pubmed/1459 ... t=Abstract
But to your point, it would be a highly surprising result if statin drugs really reduce all-cause mortality, especially given the large number of studies where no such effect has been seen. If you can give me a better pointer to the study you are citing, I will take the time to read it.
note. After putting all the responses in the same topic, I decided to try putting each issue into its own separate topic..?